March 9, 2022

Fulbright Scholarships awarded to UOW academics, alumni

Program promotes cultural, educational exchange between US and Australia

Two University of Wollongong connected academics have been named as recipients of 2022 Fulbright Scholarships.

The scholarships support professional development opportunities in the United States and promote cultural and educational exchange between the US and Australia.

UOW Senior Deputy Vice-Chancellor (Innovation, Enterprise and External Relations) Professor Alex Frino was named as a recipient of a Fulbright Scholar Award. Professor Frino is a two-time Fulbright Awardee, having previously been hosted by Georgetown University in 2005.

UOW alumnus and Illawarra Health and Medical Research Institute (IHMRI) affiliated researcher Dr Thomas Guy was awarded a Fulbright Future Scholarship. Dr Guy graduated as a Doctor of Medicine from UOW in 2018.

Professor Alex Frino is one of the best published financial economists in the world with over 100 papers in leading scholarly journals. He has been ranked among the top 150 scholars in his field globally by an influential survey of finance researchers.

Professor Frino will be travelling to the US to work with scholars in the Cyber Security Department at Florida Polytechnic University and his research project will examine the impact of cyber attacks on listed companies in NATO countries.

Professor Frino graduated from the University of Wollongong with a Bachelor of Commerce in 1988 and a Master of Commerce (Honours) in 1989. He also holds postgraduate degrees from the University of Sydney and Cambridge University.

Dr Guy is a clinician researcher training at Royal Prince Alfred Hospital in Sydney.

His long-term interest lies in immunotherapy treatments for cancer. He wants to understand why some cancers are cured by immunotherapy but not others, with the ultimate goal to improve cancer treatments and the lives of patients with cancer.

Building on his PhD work and clinical research, Dr Guy will join Professor Pillai’s group at the Ragon Institute of Massachusetts General Hospital, MIT and Harvard.

He will learn state-of-the-art technologies at this NIH-funded Autoimmune Center of Excellence and bring these skills back to further his IHMRI based cancer research.